The case for & against
Bull & Bear analysis
Bearish
White Mountains Insurance Group (NYSE: WTM) is a specialized insurance and reinsurance company operating within the financial services sector. The firm focuses on property and casualty insurance, with a reputation for a strong underwriting performance. It has developed a competitive edge through streamlined operations and diversified product offerings, focusing on distinguishing itself in a market characterized by heightened competition and regulatory oversight. The company is part of the broader trend towards enhanced risk management and innovative insurance solutions, capitalizing on market dislocations and evolving consumer demands.
Bull says
- ↑Earnings yield of 0.71 indicates trading at a discount to earnings
- ↑Book-to-price ratio of 0.86 underpins strong asset backing
- ↑Positive momentum reflects recent price gains and market interest
- ↑Historical volatility remains low, offering stability for risk-averse investors
- ↑Favorable interest-rate sensitivity may boost investment income if rates rise
- ↑Analysts forecast Q2 EPS of $75 and revenue of $570M, implying rebound
Bear says
- ↓Q1 2026 EPS loss of $12.59 far below consensus loss of $4.00
- ↓Insiders sold $21M in shares over past year, raising confidence concerns
- ↓Negative growth outlook suggests challenges expanding P&C premiums
- ↓Recent analyst downgrades to sell and hold reflect waning outlook
- ↓Institutional ownership under 2% indicates limited buy-in from major investors
- ↓Modest profitability metrics and no dividend weigh on shareholder returns
Investment themes with WTM
L&H Insurance↓ -0.09%
PGR · TRV · ALL
Earnings Call · Q4 2025 · Mgmt. Guidance
Updated 08-05-2026neutral
Transcript signals
Bull points
- 2025 was a record year. We crossed several significant milestones. $2 billion of transaction value, $1 billion of revenue, and $100 million of adjusted EBITDA, all for the first time.
- We expect take rates in Q1 to be above Q4 levels.
- Based on our strong and growing free cash flow outlook, our board has authorized a $50 million increase in our share repurchase program to $100 million.
Bear points
- Revenue was $291 million, down 3% year-over-year as reported, but up 9% excluding under 65 health. Health declines were mostly offset by P&C growth.
- Adjusted EBITDA was $30.8 million, down 16% year over year.
- We expect first quarter transaction value in our health insurance vertical to decline approximately 50% year-over-year, driven primarily by under 65 health.
Read full transcript analysis ›